| [1] Nusse R, Brown A, Papkoff J, et al. A new nomenclature for int-1 and related genes: the Wnt gene family. Cell. 1991;64(2): 231.[2] Rijsewijk F, Schuermann M, Wagenaar E, et al. The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell. 1987; 50(4):649-657.[3] Gordon MD, Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem. 2006;281(32):22429-22433.[4] Angers S, Moon RT. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol. 2009;10(7):468-477.[5] Croce JC, Mcclay DR. Evolution of the Wnt pathways. Methods Mol Biol. 2008;469:3-18.[6] Nusse R. Wnt signaling and stem cell control. Cell Res. 2008; 18(5):523-527.[7] Alves DSM, Smidt MP. En1 and Wnt signaling in midbrain dopaminergic neuronal development. Neural Dev. 2011:6:23.[8] Carlson ME, Silva HS, Conboy IM. Aging of signal transduction pathways, and pathology. Exp Cell Res. 2008; 314(9):1951-1961.[9] Macdonald B T, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009; 17(1):9-26.[10] Kwon C, Cordes KR, Srivastava D. Wnt/beta-catenin signaling acts at multiple developmental stages to promote mammalian cardiogenesis. Cell Cycle. 2008;7(24): 3815-3818.[11] Boonen RA, van Tijn P, Zivkovic D. Wnt signaling in Alzheimer's disease: up or down, that is the question. Ageing Res Rev. 2009;8(2):71-82.[12] Roe CM, Fitzpatrick A L, Xiong C, et al. Cancer linked to Alzheimer disease but not vascular dementia. Neurology. 2010;74(2):106-112.[13] Huang H, He X. Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol. 2008;20(2): 119-125.[14] Chien AJ, Conrad WH, Moon RT. A Wnt survival guide: from flies to human disease. J Invest Dermatol. 2009;129(7): 1614-1627.[15] De A. Wnt/Ca2+ signaling pathway: a brief overview. Acta Biochim Biophys Sin (Shanghai). 2011;43(10):745-756.[16] Lamonica K, Grabel L. The planar cell polarity pathway and parietal endoderm cell migration. Methods Mol Biol.2012; 839:187-200.[17] Querfurth HW, Laferla FM. Alzheimer's disease. N Engl J Med. 2010;362(4):329-344.[18] Roychaudhuri R, Yang M, Hoshi MM, et al. Amyloid beta-protein assembly and Alzheimer disease. J Biol Chem. 2009;284(8):4749-4753.[19] Magdesian MH, Carvalho MM, Mendes FA, et al. Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling. J Biol Chem. 2008;283(14):9359-9368.[20] Shruster A, Eldar-Finkelman H, Melamed E, et al. Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid beta-peptide. J Neurochem. 2011;116(4):522-529.[21] Zhou F, Gong K, van Laar T, et al. Wnt/beta-catenin signal pathway stabilizes APP intracellular domain (AICD) and promotes its transcriptional activity. Biochem Biophys Res Commun. 2011;412(1):68-73.[22] Zhou F, Gong K, Song B, et al. The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth. Biochim Biophys Acta. 2012;1823(8):1233-1241.[23] Maguschak KA, Ressler KJ. The dynamic role of beta-catenin in synaptic plasticity. Neuropharmacology. 2012;62(1):78-88.[24] De Ferrari GV, Chacon MA, Barria MI, et al. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol Psychiatry. 2003;8(2):195-208.[25] Quintanilla RA, Munoz FJ, Metcalfe MJ, et al. Trolox and 17beta-estradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. J Biol Chem. 2005;280(12): 11615-11625.[26] Alvarez AR, Godoy JA, Mullendorff K, et al. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Exp Cell Res. 2004;297(1):186-196.[27] Roberson ED, Scearce-Levie K, Palop JJ, et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science. 2007;316 (5825): 750-754.[28] Blalock EM, Geddes JW, Chen KC, et al. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A.2004;101(7):2173-2178.[29] Noble W, Planel E, Zehr C, et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A.2005;102(19):6990-6995.[30] Chiu CT, Chuang DM. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther.2010;128(2):281-304.[31] Engel T, Hernandez F, Avila J, et al. Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. J Neurosci.2006;26(19):5083-5090.[32] Jessberger S, Gage FH. Fate plasticity of adult hippocampal progenitors: biological relevance and therapeutic use. Trends Pharmacol Sci. 2009;30(2):61-65.[33] Ming GL, Song H. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci. 2005;28: 223-250.[34] Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?. Nat Rev Neurosci.2010;11(5): 339-350.[35] Blennow K. Dementia in 2010: Paving the way for Alzheimer disease drug development. Nat Rev Neurol.2011;7(2):65-66.[36] Abdel-Salam OM. Stem cell therapy for Alzheimer's disease. CNS Neurol Disord Drug Targets.2011;10(4):459-485.[37] Esmaeilzade B, Nobakht M, Joghataei MT, et al. Delivery of Epidermal Neural Crest Stem Cells (EPI-NCSC) to hippocamp in Alzheimer's Disease Rat Model. Iran Biomed J. 2012;16(1):1-9.[38] Inestrosa NC, Arenas E. Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci. 2010;11(2):77-86.[39] Muroyama Y, Kondoh H, Takada S. Wnt proteins promote neuronal differentiation in neural stem cell culture. Biochem Biophys Res Commun. 2004;313(4):915-921.[40] Yu JM, Kim JH, Song GS, et al. Increase in proliferation and differentiation of neural progenitor cells isolated from postnatal and adult mice brain by Wnt-3a and Wnt-5a. Mol Cell Biochem. 2006;288(1-2):17-28.[41] Wexler EM, Geschwind DH, Palmer TD. Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry. 2008;13(3): 285-292.[42] Yoshinaga Y, Kagawa T, Shimizu T, et al. Wnt3a promotes hippocampal neurogenesis by shortening cell cycle duration of neural progenitor cells. Cell Mol Neurobiol. 2010;30(7): 1049-1058.[43] He P, Shen Y. Interruption of beta-catenin signaling reduces neurogenesis in Alzheimer's disease. J Neurosci. 2009;29 (20): 6545-6557.[44] Zilka N, Zilkova M, Kazmerova Z, et al. Mesenchymal stem cells rescue the Alzheimer's disease cell model from cell death induced by misfolded truncated tau. Neuroscience. 2011;193:330-337.[45] Lee JK, Schuchman EH, Jin HK, et al. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses. Stem Cells. 2012;30(7):1544-1555.[46] Chen BY, Wang X, Chen L W, et al. Molecular targeting regulation of proliferation and differentiation of the bone marrow-derived mesenchymal stem cells or mesenchymal stromal cells. Curr Drug Targets. 2012;13(4):561-571.[47] Kondo T, Matsuoka AJ, Shimomura A, et al. Wnt signaling promotes neuronal differentiation from mesenchymal stem cells through activation of Tlx3. Stem Cells. 2011;29(5): 836-846.[48] Xiang XX, Chen L, Wang JH, et al. Role of Wnt/beta-catenin signaling in aging of mesenchymal stem cells of rats. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011;40(6):630-640.[49] Wang CY, Zheng W, Wang T, et al. Huperzine A activates Wnt/beta-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model. Neuropsychopharmacology.2011;36(5):1073-1089.[50] Wei LC, Ding YX, Liu YH, et al. Low-dose radiation stimulates Wnt/beta-catenin signaling, neural stem cell proliferation and neurogenesis of the mouse hippocampus in vitro and in vivo. Curr Alzheimer Res. 2012;9(3):278-289. |
